Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ.DE)

EUR 45.28

(1.71%)

Market Cap (In EUR)

943.88 Million

Revenue (In EUR)

246.09 Million

Net Income (In EUR)

26.3 Million

Avg. Volume

28.31 Thousand

Currency
EUR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
32.74-50.05
PE
-
EPS
-
Beta Value
1.333
ISIN
DE0005659700
CUSIP
D2371P107
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Dr. Harald Hasselmann
Employee Count
-
Website
https://www.ezag.com
Ipo Date
1999-05-26
Details
Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide. It operates in two segments, Medical and Isotope Products. The Medical segment offers small radioactive implants for the treatment of prostate cancer seeds; and eye application based on ruthenium-106 or iodine-125 for treating uveal melanoma. This segment also provides radiopharmaceuticals, laboratory equipment, hot cells, and services for radiopharmaceuticals, as well as eye applicators and prostate implants. The Isotope Products segment manufactures and sells radiation sources for imaging, measurement technology, material analysis, quality assurance, and environmental monitoring. This segment also offers calibration sources for medical imaging systems, and homeland security and radiometric level measurement products. The company was founded in 1992 and is headquartered in Berlin, Germany.